*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Formulation and Evaluation of Disopyaramide Phosphate Loaded Microbeads

Author: MANDAKINI HOLKAR, SNEHAL CHAKORKAR, JAGADEVAPPA S PATIL
Abstract: Background: Disopyramide Phosphate, an anti-arrhythmic drug, and has oral bioavailability of 80% with a 6-8 hour biological half-life. Presently, on the lookout, various extended-release formulations of Disopyramide phosphate are available. Objectives: In the current research, we specifically recommended the use of natural polymer to design the extended-release formulation, which improves the biocompatible property of the dosage form as compared with the conventional release dosage form. chitosan is picked as a copolymer to obtain promising sustained release action alongside mucoadhesive action. Methods: Sustained release beads of Disopyramide phosphate were prepared by ionotropic gelation technique involve; within the sight of counterions, polyelectrolytes can cross-link and structure a coat on the drug core to form hydro gels with sustain release action. In current work, microbeads are formulated utilizing various extents of sodium alginate with or without chitosan and evaluated for, FTIR, DSC, Visual Appearance, SEM, Particle size, Percentage Yield of microbeads, Drug Entrapment Efficiency, Swelling Index, In-Vitro Dissolution Studies, Release kinetic study and Stability study. Result: The formulated Disopyramide phosphate loaded microbeads show maximum drug Entrapment Efficiency, Swelling Index, In-Vitro Dissolution Studies, Release kinetic study, and Stability study. The formulation S2 was oppressed for data modeling of zero-order, Higuchi, and Korsmeyer Peppas equation, studies showed that all formulations followed zero order r2 value 0.984, Higuchi r2 0.916, and Peppas n value 0.892. The release data from all the formulation was found to fit zero-order models. The S2 formulation demonstrated high drug entrapment efficiency and a possible sustained release profile from microbeads.Mandakini Holkar et al / Formulation and Evaluation of Disopyaramide Phosphate Loaded Microbeads 2765| International Journal of Pharmaceutical Research | Apr - Jun 2021 | Vol 13 | Issue 2 Conclusion: From the experimental findings it tends to be gathered that the formulated Disopyramide phosphate microbeads show the stable sustain release action.
Keyword: Antiarrhythmic agent; Ionotropic gelation; chitosan; Microbeads Disopyramide phosphate
DOI: https://doi.org/10.31838/ijpr/2021.13.02.161
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free